Neoadjuvant Targeted Therapy for Resectable ALK-fusion Locally Advanced Non-small Cell Lung Cancer

被引:0
|
作者
Zhao, D. [1 ]
Wu, N. [1 ]
机构
[1] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
关键词
Neoadjuvant; Targeted therapy; ALK-fusion;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-02
引用
收藏
页码:S295 / S296
页数:2
相关论文
共 50 条
  • [21] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Lochrin, Sarah E.
    Forde, Patrick M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (08) : 415 - 423
  • [22] Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
    Cameron, L. B.
    Hitchen, N.
    Chandran, E.
    Morris, T.
    Manser, R.
    Solomon, B. J.
    Jordan, V
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (01):
  • [23] Outcomes of Resectable Locally Advanced Non-Small Cell Lung Cancer After Neoadjuvant Chemoimmunotherapy: A Single Institution Experience
    Noy, Jose
    Chang, Alexander
    Chow, Nelly P.
    De Jesus Fernandez, Javier
    Dureja, Rohan
    Cotamo, Luis Miguel
    Alnajar, Ahmed
    Nguyen, Dao M.
    Villamizar, Nestor
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [24] Adjuvant therapy for locally advanced non-small cell lung cancer
    Keller, SM
    LUNG CANCER, 2003, 42 : S29 - S34
  • [25] Trimodality therapy for locally advanced non-small cell lung cancer
    Lackner, R. P.
    Ganti, A.
    Zhen, W.
    Copur, M. S.
    Vaziri, I. A.
    Bolton, M.
    Hlavaty, T.
    Trujillo, K. P.
    Kessinger, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Proton therapy for locally advanced non-small cell lung cancer
    Gjyshi, Olsi
    Liao, Zhongxing
    BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1107):
  • [27] Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
    Hu, Yan
    Ren, Siying
    Yang, Lulu
    Tong, Zhongyi
    Wang, Ruoyao
    Han, Wei
    Zeng, Chao
    Li, Jina
    Xiao, Peng
    Wang, Li
    Yu, Fenglei
    Liu, Wenliang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    LUNG CANCER, 2023, 183
  • [29] No Benefit for Extending Neoadjuvant Targeted Therapy Exposure Time in Resectable EGFR Mutation Non-small Cell Lung Cancer
    Zhang, S.
    Yan, S.
    Wu, N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S586 - S587
  • [30] Treatment of locally advanced non-small cell lung cancer - neoadjuvant or adjuvant chemotherapy
    Vokes, Everett E.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S237 - S237